A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

January 26, 2028

Study Completion Date

May 16, 2028

Conditions
Advanced Non-Small Cell Lung Cancer
Interventions
DRUG

BNT116

BNT116 is administered by IV injection.

DRUG

Cemiplimab

Cemiplimab is administered Q3W by IV infusion

Trial Locations (52)

114

Tri-Service General Hospital, Taipei

744

Seoul National University Hospital, Seoul

807

Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung City

3722

Yonsei Severance, Seoul

6000

LTD High Technology Hospital Medcenter, Batumi

6351

Samsung Medical Center, Seoul

10065

Weill Cornell Medicine, New York

10408

National Cancer Center Korea, Goyang

12002

Consorcio Hospitalario Provincial de Castellon, Castellon

22031

Virginia Cancer Specialists, Fairfax

23142

Taipei Tzu Chi Hospital, New Taipei City

23561

Taipei Medical University - Shuang Ho Hospital, New Taipei City

28007

Hospital General Universitario Gregorio Marañon (HGUGM), Madrid

28027

Clinica Universidad de Navarra - Madrid, Madrid

28040

Hospital Universitario Fundacion Jimenez Diaz, Madrid

28374

FirstHealth of the Carolinas Outpatient Cancer Center, Pinehurst

29010

Hospital Regional Universitario de Malaga, Málaga

Hospital Universitario Virgen del Rocio, Málaga

31008

Clinica Universidad de Navarra, Pamplona

34093

Bezmialem Foundation University Medical Faculty, Istanbul

34718

Yeditepe University Kosuyolu Hospital, Kadıköy

35100

Ege University Faculty of Medicine, Bornova

35325

Izmir Economy University Medical Point Hospital, Izmir

40202

Norton Cancer Institute, Downtown, Louisville

46009

Instituto Valenciano de Oncologia, Valencia

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

58128

Chonnam National University Hwasun Hospital, Hwasun

60590

Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt, Frankfurt

77090

Millenium Research & Clinical Development, Houston

80336

Universitaetsklinikum Giessen Und Marburg Gmbh Standort Giessen, Giessen

81450

Istanbul Medeniyet University - Prof Dr Suleyman Yalcin Sehir Hospital, Istanbul

81925

Staedtisches Klinikum Muenchen Bogenhausen, München

87349

Klinikverbund Kempten-Oberallgäu, Kempten

87401

San Juan Oncology Associates, Farmington

90033

The Oncology Institute of Hope and Innovation, Los Angeles

90095

UCLA Medical Center, Santa Monica

98405

Northwest Medical Specialties, PLLC, Tacoma

100225

National Taiwan University Hospital, Taipei

0112

LLC Todua Clinic, Tbilisi

0114

LTD New Hospitals, Tbilisi

0144

LTD Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic, Tbilisi

0179

LTD Cancer Research Centre, Tbilisi

0186

Caucasus Medical Centre, Tbilisi

06120

Krankenhaus Martha-Maria Halle-Doelau gGmbH, Halle

02841

Korea University Anam Hospital, Seoul

05505

Asan Medical Center, Seoul

08916

Catalan Institute of Oncology Badalona, Badalona

08243

Althaia Xarxa Assistencial Universitaria Manresa, Manresa

01140

Adana Medical Park Seyhan Hospital, Adana

01230

Baskent University, Yüreğir

06100

Ozel Liv Hospital, Ankara

Sbu Doctor Abdurrahman Yurtaslan Ankara Onkoloji Suam, Ankara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioNTech SE

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT05557591 - A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) | Biotech Hunter | Biotech Hunter